![Person eye](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2024/04/pexels-photo-865711-e1713646203678.jpeg?resize=734%2C400&ssl=1)
Ocugen Advances in Revolutionary Gene Therapy for Age-Related Macular Degeneration
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reached a significant milestone in the development of a groundbreaking treatment for geographic atrophy (GA), an advanced form of dry age-related macular …
Ocugen Advances in Revolutionary Gene Therapy for Age-Related Macular Degeneration Read More